<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> plays an important role in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and in humans IL-10 may have a beneficial effect in <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We mucosally administered myelin oligodendrocyte <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> (MOG) 35-55 peptide to C57BL/6 mice before middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) to induce an anti-inflammatory T cell response directed at <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> myelin </plain></SENT>
<SENT sid="2" pm="."><plain>Nasal and oral administration of MOG(35-55) <z:chebi fb="7" ids="16670">peptide</z:chebi> decreased ischemic <z:mpath ids='MPATH_124'>infarct</z:mpath> size at 24 and 72 h after MCAO surgery </plain></SENT>
<SENT sid="3" pm="."><plain>Nasal MOG(35-55) <z:chebi fb="7" ids="16670">peptide</z:chebi> was most efficacious and reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size by 70% at 24 h and by 50% at 72 h (p &lt;or= 0.0001 vs control) and also improved behavior score </plain></SENT>
<SENT sid="4" pm="."><plain>Immunohistochemistry demonstrated increased IL-10 and reduced IFN-gamma in the area surrounding the ischemic <z:mpath ids='MPATH_124'>infarct</z:mpath> following nasal treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Nasal MOG did not reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> size in IL-10-deficient mice </plain></SENT>
<SENT sid="6" pm="."><plain>Adoptive transfer of CD4(+) T cells to untreated mice from nasally tolerized mice before MCAO surgery decreased <z:hpo ids='HP_0001297'>stroke</z:hpo> size (p &lt; 0.001 vs control), whereas, CD4(+) T cells from nasally tolerized IL-10-deficient mice had no effect </plain></SENT>
<SENT sid="7" pm="."><plain>Our results demonstrate that IL-10-secreting CD4(+) T cells induced by nasal MOG reduce injury following <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, we observed a dramatic reduction of CD11b(+) cells in nasal MOG-treated animals </plain></SENT>
<SENT sid="9" pm="."><plain>CD11b(+) cells may contribute to secondary <z:mpath ids='MPATH_124'>infarct</z:mpath> expansion by enhancing NO synthesis that may be reduced by elevated IL-10 levels </plain></SENT>
<SENT sid="10" pm="."><plain>Modulation of cerebral <z:mp ids='MP_0001845'>inflammation</z:mp> by nasal vaccination with myelin Ags that increase IL-10 in the brain may improve outcome after <z:hpo ids='HP_0001297'>stroke</z:hpo> and enhance mechanisms of recovery </plain></SENT>
</text></document>